Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Titel:
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Auteur:
Aggarwal, Rahul Starzinski, Stephanie de Kouchkovsky, Ivan Koshkin, Vadim Bose, Rohit Chou, Jonathan Desai, Arpita Kwon, Daniel Kaushal, Samuel Trihy, Lauren Rastogi, Medini Ippisch, Robin Aslam, Maya Friedlander, Terence Feng, Felix Oh, David Cheung, Alexander Small, Eric Evans, Michael Fong, Lawrence Hope, Thomas A
Verschenen in:
Lancet oncology
Paginering:
Jaargang 24 () nr. 11 pagina's 1266-1276
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license